IGF1-LR3 Scientific Profile

1. Introduction

IGF1-LR3 (Insulin-like Growth Factor-1 Long R3) is a powerful analog of the native human Insulin-like Growth Factor-1 (IGF-1) protein. This document outlines the key scientific characteristics and research applications of IGF1-LR3, focusing on its role as a primary tool for investigating cellular proliferation mechanisms. As an experimental reagent, it is critical for researchers to understand its specific potency and biological scope.

2. Molecular and Functional Profile

IGF1-LR3 is an 83-amino acid analog of human IGF-1, featuring the substitution of an Arginine for a Glutamic Acid at the third position (hence R3) and a 13-amino acid extension at the N-terminus. These modifications significantly alter its interaction with binding proteins and its overall half-life.

The primary research utility of IGF1-LR3 lies in its ability to drive cellular hyperplasia—the increase in the number of cells—which differentiates it from agents that only promote hypertrophy (increase in cell size).

2.1. Potency and Pharmacokinetics

The structural modifications of IGF1-LR3 are designed to minimize binding to the native IGF Binding Proteins (IGFBPs).

Feature

Native IGF-1

IGF1-LR3

Significance for Research

Amino Acids

70

83

Extended N-terminus

IGFBP Binding

High

Low

Increased bioavailability

Clearance Rate

Rapid

Reduced

Extended duration of action

Cell Activation

Baseline

Approximately 3x Baseline

Enhanced research potency

This reduced clearance is the mechanism behind its high potency, providing approximately three times the cellular activation signal compared to native IGF-1 in research assays. This sustained signaling is crucial for long-duration cell culture or tissue engineering experiments where continuous mitogenic stimulation is required.

2.2. Mechanism of Action

IGF1-LR3 acts primarily by binding to the IGF-1 Receptor (IGF-1R), a receptor tyrosine kinase. Receptor activation initiates a cascade of intracellular events, principally involving the PI3K/Akt and MAPK pathways, which are central to regulating cell cycle progression, survival, and differentiation.

3. Cellular Differentiation and Maturation

In addition to driving proliferation, IGF1-LR3 plays a key role in the research of cellular differentiation.

3.1. Satellite Cell Maturation

A significant area of study is the process of myogenesis. IGF1-LR3 is a potent promoter of the maturation of quiescent satellite cells (adult stem cells of skeletal muscle) into fully functional, differentiated muscle fibers. This makes it an essential reagent for muscle tissue engineering research and studies of muscle repair.

3.2. Scope of Observed Effects

The proliferative and differentiating effects of IGF1-LR3 are not limited to muscle tissue. In vitro research has documented its impact across various cell lines and tissue types, including:

• Connective Tissue: Stimulation of fibroblast proliferation and matrix production.
• Liver Tissue: Research into hepatocyte regeneration and proliferation.
• Kidney Tissue: Investigation of renal cell growth and repair mechanisms.
• Nerve Tissues: Study of neuronal and glial cell proliferation and survival.

4. Ideal Research Applications

IGF1-LR3 is best suited for research environments requiring highly controlled and potent proliferative signaling.

4.1. Myoblast Culture Assays

It is an indispensable reagent for protocols focused on:

• Maximizing the expansion of primary myoblast populations before induction of differentiation.
• Studying the dose-dependent proliferative response of muscle precursor cells.
• Investigating signaling pathway dynamics under conditions of sustained IGF-1R activation.

4.2. Tissue Engineering Research

For researchers developing in vitro tissue models, IGF1-LR3 is used for:

• Enhancing the cell density and maturation of engineered muscle constructs.
• Developing scaffold-based systems for regenerative medicine.
• Exploring the role of hyperplastic growth in the repair of various organ systems.

5. Status and Regulatory Information

Status: Experimental Reagent

IGF1-LR3 is strictly for in vitro research use and is not approved for human or animal therapeutic use. Researchers must adhere to all institutional and regulatory guidelines pertaining to the use of experimental peptides and growth factors.

6. Storage and Handling

For optimal stability and potency, IGF1-LR3 should be handled according to standard protein handling protocols.

Condition

Requirement

Storage (Lyophilized)

Below -20°C

Storage (Reconstituted)

2°C to 8°C (Short-term) or below -20°C (Long-term)

Reconstitution Solvent

Sterile water or bacteriostatic water for injection (BWI)

7. Safety Data Sheet and Documentation

Further detailed safety and handling information is available in the complete Safety Data Sheet (SDS) and Certificate of Analysis (CoA), which can be accessed via File. For any inquiries regarding its use or availability, please contact Person at Place.

Please be sure to review the necessary safety guidelines before starting the experiment by clicking on the document File and attending the safety briefing event Calendar event which is scheduled for Date.The user is at the end of the document, within Section 7 ("Safety Data Sheet and Documentation"). The current section ends with a request to review safety guidelines and attend a briefing.

To continue the scientific profile document in a logical and professional manner, the next section should typically summarize the key experimental takeaways or provide a concluding statement. Given the depth of the preceding content, a brief conclusion summarizing its utility is appropriate.

1. Conclusion

IGF1-LR3 represents a highly valuable and potent research tool for the comprehensive study of cellular proliferation, differentiation, and tissue engineering. Its modified structure ensures high bioavailability and sustained receptor activation, making it superior to native IGF-1 in many in vitro and ex vivo research models requiring robust mitogenic signaling. Continued research utilizing this peptide is essential for advancing our understanding of regenerative biology, myogenesis, and cell cycle regulation.